Dysfunctional Tear Syndrome (DTS)
Last edited 09/2019 and last reviewed 11/2020
DTS (Dysfunctional Tear Syndrome) is a disorder of the tear film in quality and/or quantity, which is caused by a range of aetiologies and involves abnormalities in one or more components of the tear film, resulting in a constellation of signs and symptoms affecting the ocular surface
- any alteration in the quantity and/or quality of the tear film can result
in DTS, a chronic condition with multiple subtypes that include dry eye disease
(DED) and associated tear film disorders
- possible symptoms of DTS are:
- ocular discomfort
- dryness
- burning/stinging
- grittiness/foreign body sensation
- photophobia
- blurred/fluctuating vision
- overlap and frequent comorbidity of DED and other conditions affecting
the quantity or quality of the tear film require careful examination of patients
with DTS
- four main subtype classifications used by the DTS Panel approach are as
follows:
- aqueous deficiency;
- blepharitis/Meibomian Gland Dysfunction (MGD) (evaporative and nonevaporative);
- goblet cell deficiency/ mucin deficiency;
- exposure-related DTS
- following the clinical assessment and evaluation of a patient with DTS, each patient can be classified into one or more of the disease-state subtypes (the presence of multiple subtypes within a patient is common)
Management options include:
- artificial tears, gels, ointments, and inserts are used to replenish the
tear film
- tears can be conserved via punctal plugs, cautery, and moisture chamber eyewear
- alterations in environmental conditions may benefit patients with DTS through increases in relative humidity
- adjustments in lid hygiene, warm compresses, and massage may also be necessary for patients with blepharitis/MGD
- anti-inflammatory and immunomodulatory agent options include:
- cyclosporine, lifitegrast, steroids, and nutritional supplements, such as omega-3 fatty acids
Reference:
- Behrens A, Doyle JJ, Stern L, et al., Dysfunctional Tear Syndrome Study Group. Dysfunctional tear syndrome: a Delphi approach to treatment recommendations. Cornea 2006; 25:900-907.
- American Academy of Ophthalmology Cornea/External Disease Panel. Preferred practice pattern guidelines. Dry eye syndrome. San Francisco, CA: American Academy of Ophthalmology; 2013.